DTPa-HBV-IPV/Hib (Infanrix hexa™)

BIOLOGICAL2 trials

Sponsors

GlaxoSmithKline

Conditions

Acellular PertussisDiphtheriaHaemophilus Influenzae Type bHaemophilus Influenzae Type b (Hib)Hepatitis BPertussisPoliomyelitisTetanus

Phase 3

Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib, Compared to DTPa-HBV-IPV and Hib Administered Separately

CompletedNCT01457508

GlaxoSmithKlineDiphtheria, Haemophilus Influenzae Type b (Hib), Hepatitis B +3

Start: 1999-01-31End: 2000-03-31Updated: 2017-06-16

Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib Vaccine Followed by the Same Vaccine and Oral Polio Vaccine

CompletedNCT01457560

GlaxoSmithKlineAcellular Pertussis, Diphtheria, Haemophilus Influenzae Type b +3

Start: 2000-02-29End: 2001-04-30Updated: 2016-08-05